Fundraising Fox

Nathalie Franchimont

Chief Medical Officer at Beeline Medicines

Greater Boston

Find your path to Nathalie

287 people in our graph share verified history with Nathalie — schools, employers, funds. One of them is your warm intro.

Kelli McKeirnanunlockedNathalie: together at Amgen (2010–2012)
×6Nathalie: together at Amgen
×5Nathalie: together at Yale School of Medicine

Chief Medical Officer at Beeline Medicines

Intro paths

→

In turn, Nathalie can intro founders to Beeline Medicines's investors below.

Beeline Medicines's investors · 2

Bain CapitalBain Capital Life SciencesBoston

Experience

  1. Beeline MedicinesChief Medical Officercurrent2025 — presentCambridge, MA
  2. OMass TherapeuticsBoard Membercurrent2020 — present
  3. Nimbus TherapeuticsAdvisor2025United States
  4. Nimbus TherapeuticsChief Medical Officer2022 — 2024Massachusetts, United States
  5. BiogenSenior Vice President, Head of Multiple Sclerosis and Immunology Development Unit2020 — 2022
  6. BiogenVice President, Head of MS and Immunology Development Unit2020Cambridge, Massachusetts, United States
  7. BiogenVice President MS RU2018 — 2020Cambridge, Massachusetts
  8. BiogenVice President Ophthalmology, Pain and New Indications Research and Early Development Unit2017 — 2020Cambridge, Massachusetts
  9. BiogenVice President New Indications Research and Early Development Unit2017Cambridge, Massachusetts
  10. BiogenVice President Immunology Drug Innovation Unit2015 — 2016Cambridge, USA
  11. BiogenSenior Medical Director Immunology2012 — 2015Cambridge, MA, USA
  12. AmgenClinical Research Director2010 — 2012
  13. Amgen Europe GmbHMedical Director International Development2008 — 2010
  14. Amgen (Europe) GmbHInt. Medical Affairs Director2005 — 2008
  15. FNRS (National Fund for Scientific Research)Research Associate (permanent position)2001 — 2005
  16. University of LiègeChief of Clinics1998 — 2005
  17. Yale Univ School of MedicineRheumatology fellow1996 — 1997
  18. Saint Francis Hospital and Medical CenterPost-doctoral Fellow in Bone Biology1994 — 1996

Skills & more

Research and Development (R&D)Business DevelopmentCMO managementBoneRheumatologyOsteoporosisClinical DevelopmentMolecular BiologyClinical ResearchClinical TrialsCell BiologyMedical Affairs
+6 moreTherapeutic AreasImmunologyBiotechnologyBiopharmaceuticalsMedicineDrug Development

Languages Dutch · English · French

From Nathalie's professional profile.

Frequently asked questions

Who is Nathalie Franchimont?
Chief Medical Officer at Beeline Medicines
Where does Nathalie Franchimont work?
Nathalie Franchimont is Chief Medical Officer at Beeline Medicines.
Where did Nathalie Franchimont go to school?
Nathalie Franchimont studied at University of Liège (Rheumatolgy, DEA); University of Liège (PhD, Biomedical Sciences, General); Yale School of Medicine (Rheumatology Fellow/Basic research).

Same school

Also attended University of Liège46

Xavier PétersInvestor at Inventures Investment PartnersSebastien GilletSenior Investment Manager at Wallonie EntreprendreGery LefebvreSenior Investment Manager at Wallonie EntreprendreBenoit FellinFund Director at White FundMarie AsanoPartner at European Circular Bioeconomy FundXavier SabatierInvestor at Bamboo Capital Partners

+ 40 more

Also attended Yale School of Medicine73

Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpElias QuijanoPrincipal at Northpond VenturesJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalAlley (Welsh) OlshanskyAdvisor at Casdin Capital

+ 67 more

Also attended The University of Connecticut School of Medicine3

Henry O'ConnellExecutive Officer, Director at Canary SpeechJames C. Gilbert, MDExecutive Officer and Manager at Guardian TherapeuticsLance BaldoChief Executive Officer at Beacontx

Shared employers

Also worked at Beeline Medicines3

Jonah CashdanVice President at Bain Capital Life SciencesSaqib IslamChief Executive Officer at Beeline MedicinesBadreddin EdrisDirector and Co-Founder at Edgewise Therapeutics

Also worked at OMass Therapeutics6

Scott BillerInvestor at GV (Google Ventures)Diana BernsteinDirector at Northpond VenturesClaire BrownPartner at Oxford Science EnterprisesMagdalena JonikasPartner at Jeito CapitalRos DeeganFounder at OmassGiles BrownExecutive VP Drug Discovery at Amphista

Also worked at Nimbus Therapeutics10

Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesVikas GoyalPartner at Longwood FundNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health Investors

+ 4 more

Also worked at Biogen98

Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityJohn McCabePortfolio Company CFO & COO at Longwood Fund

+ 92 more